ARTICLE | Company News
GlaxoSmithKline, Viiv Healthcare infectious news
May 11, 2015 7:00 AM UTC
GlaxoSmithKline said in its 1Q15 earnings announcement that it will retain its holding in ViiV, its HIV-focused JV with Pfizer Inc. (NYSE:PFE, New York, N.Y.) and Shionogi & Co. Ltd. (Tokyo:4507, Os...